• Tuhura Biosciences filed an amended 8-K to clarify terms of its 2026 Inducement Equity Incentive Plan adopted Sept. 10, 2026.
• No equity awards had been granted under the plan as of adoption.
• Future inducement grants will be disclosed via press release under Nasdaq Listing Rule 5635(c)(4).
• The board expects awards to be stock options for new hires, priced at or above the closing share price on grant date.
• Up to 5,000,000 shares reserved will not be issued until options vest and are exercised.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tuhura Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-393847), on September 17, 2026, and is solely responsible for the information contained therein.